Search research articles
Contact Us
Filters
Showing results (201-210 of 210) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 210 results.
Journal of Virology
|
April 29, 1998
Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure
J Benson, C Chougnet, M Robert-Guroff, et al.
Pharmacological Research
|
June 6, 2022
Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease
P Rossignol, J Silva-Cardoso, M N Kosiborod, et al.
Environmental Pollution (Barking, Essex : 1987)
|
November 1, 2011
Forests under climate change and air pollution: gaps in understanding and future directions for research
R Matyssek, G Wieser, C Calfapietra, et al.
Transplantation Proceedings
|
July 19, 2020
Ten-Year Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant: A Prospective Cohort Study
E L Parodi, E La Porta, R Russo, et al.
Infection and Immunity
|
May 1, 1996
Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria
D E Lanar, J A Tine, C de Taisne, et al.
Environmental Pollution (Barking, Essex : 1987)
|
August 8, 2006
Measuring, modelling and testing ozone exposure, flux and effects on vegetation in southern European conditions--what does not work? A review from Italy
M Ferretti, M Fagnano, T Amoriello, et al.
The Science of the Total Environment
|
July 21, 2019
Toward stomatal-flux based forest protection against ozone: The MOTTLES approach
E Paoletti, A Alivernini, A Anav, et al.
Infection and Immunity
|
September 1, 1996
NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria
J A Tine, D E Lanar, D M Smith, et al.
The Journal of Infectious Diseases
|
May 21, 1998
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group
M L Clements-Mann, K Weinhold, T J Matthews, et al.
Annali Dell'Istituto Superiore Di Sanita
|
January 1, 1979
[Nutritional research on Toprina (yeasts cultivated on n-paraffins)]
R Alimenti, G Antonucci, M P Bernardini, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 210) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 210 results.
Journal of Virology
|
April 29, 1998
Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure
J Benson, C Chougnet, M Robert-Guroff, et al.
Pharmacological Research
|
June 6, 2022
Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease
P Rossignol, J Silva-Cardoso, M N Kosiborod, et al.
Environmental Pollution (Barking, Essex : 1987)
|
November 1, 2011
Forests under climate change and air pollution: gaps in understanding and future directions for research
R Matyssek, G Wieser, C Calfapietra, et al.
Transplantation Proceedings
|
July 19, 2020
Ten-Year Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant: A Prospective Cohort Study
E L Parodi, E La Porta, R Russo, et al.
Infection and Immunity
|
May 1, 1996
Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria
D E Lanar, J A Tine, C de Taisne, et al.
Environmental Pollution (Barking, Essex : 1987)
|
August 8, 2006
Measuring, modelling and testing ozone exposure, flux and effects on vegetation in southern European conditions--what does not work? A review from Italy
M Ferretti, M Fagnano, T Amoriello, et al.
The Science of the Total Environment
|
July 21, 2019
Toward stomatal-flux based forest protection against ozone: The MOTTLES approach
E Paoletti, A Alivernini, A Anav, et al.
Infection and Immunity
|
September 1, 1996
NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria
J A Tine, D E Lanar, D M Smith, et al.
The Journal of Infectious Diseases
|
May 21, 1998
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group
M L Clements-Mann, K Weinhold, T J Matthews, et al.
Annali Dell'Istituto Superiore Di Sanita
|
January 1, 1979
[Nutritional research on Toprina (yeasts cultivated on n-paraffins)]
R Alimenti, G Antonucci, M P Bernardini, et al.
Page
of 21